What are the most valued startups in the deep tech market?

Last updated: 13 July 2026

This monthly refreshed ranking tracks the most valuable startups and technology companies in the deep tech market.

market research pitch 2026

In our updated market reports, you will find everything you need

The deep tech market includes companies building technologies based on advanced engineering, scientific research and difficult-to-replicate intellectual property.

This ranking covers major areas such as space technology, robotics, quantum computing, semiconductors, biotechnology, energy storage and autonomous systems.

We update this list every month to reflect new funding rounds, public market movements, acquisitions and other valuation signals.

A quick summary table

Metric Value
Most valuable deep tech company SpaceX, $2.0T
Second most valuable deep tech company Blue Origin, $120.0B–$140.0B
Median deep tech valuation Approximately $2.0B
Share of deep tech valuation captured by the top 10 Approximately 91.5%
Top deep tech valuation vs. median Approximately 1,000 times
Median deep tech valuation-to-capital-raised ratio Approximately 3.8 times
Deep tech companies valued at $1B+ 68

Top startups in the deep tech market ranked by valuation

Here is an updated table that ranks the top startups in the deep tech market based on their latest reported or estimated valuations.

# Startup Name What They Do Current Valuation ($) Valuation Confidence Level Valuation Type Evidence Status Total Funding ($) Funding Confidence Level
1 SpaceX Rockets, satellites, space internet $2.0T Full Confidence Public Market Cap Observed $86.9B Partial Confidence
2 Blue Origin Rockets and space infrastructure $120.0B–$140.0B Partial Confidence Active Raise Valuation Estimated Not provided Low Confidence
3 Cambricon Technologies Designs AI accelerator chips $130.0B Full Confidence Public Market Cap Observed $1.3B Partial Confidence
4 Figure AI General-purpose humanoid robots $39.0B Full Confidence Announced Private Round Valuation Observed $1.8B+ Strong Confidence
5 Boston Dynamics Builds advanced mobile robots $20.0B–$24.0B Partial Confidence Proxy-Based Estimate Estimated Not provided Low Confidence
6 IonQ Trapped-ion quantum computing systems $16.6B Full Confidence Public Market Cap Observed $3.1B Strong Confidence
7 Isomorphic Labs AI-powered drug design platform $14.0B–$18.0B Partial Confidence Implied Valuation from Raise Implied $2.7B Strong Confidence
8 Skild AI General-purpose robotics foundation models $14.0B–$14.5B Strong Confidence Announced Private Round Valuation Observed $1.8B Strong Confidence
9 Shield AI Autonomous defense aircraft software $12.0B–$12.7B Strong Confidence Active Raise Valuation Observed $1.0B Partial Confidence
10 Cerebras Systems Builds wafer-scale AI computers $12.5B Full Confidence Public Market Cap Observed $9.2B Partial Confidence
11 Physical Intelligence Develops foundation models for robots $10.0B–$12.0B Partial Confidence Active Raise Valuation Estimated $1.9B Partial Confidence
12 Colossal Biosciences Develops de-extinction genetic technologies $10.0B–$11.5B Strong Confidence Announced Private Round Valuation Estimated $435M Full Confidence
13 Planet Labs Operates daily Earth-imaging satellites $9.4B Full Confidence Public Market Cap Observed $906M Strong Confidence
14 Quantum Systems Builds AI-enabled defense drones $8.0B Strong Confidence Announced Private Round Valuation Observed $1.7B Strong Confidence
15 Groq AI inference chips and cloud $6.9B–$8.5B Strong Confidence Implied Valuation from Raise Implied $1.8B Strong Confidence
16 D-Wave Quantum Builds quantum annealing systems $7.8B Full Confidence Public Market Cap Observed $296M Partial Confidence
17 Zipline Autonomous drone delivery logistics $7.6B Full Confidence Announced Private Round Valuation Observed $1.4B Strong Confidence
18 PsiQuantum Develops photonic fault-tolerant quantum computers $7.0B Strong Confidence Announced Private Round Valuation Observed $1.7B Partial Confidence
19 Unitree Robotics Humanoid and quadruped robots $6.0B–$8.0B Partial Confidence IPO or Listing Range Valuation Estimated $237M Partial Confidence
20 Redwood Materials Recycles batteries and produces materials $6.0B–$6.3B Strong Confidence Announced Private Round Valuation Observed $2.2B Strong Confidence
21 Symbotic Warehouse robotics automation $5.8B Full Confidence Public Market Cap Observed $725M Low Confidence
22 Rigetti Computing Builds superconducting quantum computers $5.7B Full Confidence Public Market Cap Observed $278M Strong Confidence
23 Apptronik Builds humanoid robots $5.0B–$5.8B Strong Confidence Announced Private Round Valuation Observed $1.0B Strong Confidence
24 Lightmatter Photonic interconnects for AI computing $4.0B–$5.0B Strong Confidence Announced Private Round Valuation Estimated $850M Strong Confidence
25 Firefly Aerospace Launch and lunar spacecraft $4.6B Full Confidence Public Market Cap Observed $1.5B Partial Confidence
26 XtalPi AI drug and materials discovery $4.3B Full Confidence Public Market Cap Observed $785M Partial Confidence
27 Geek+ Autonomous warehouse mobile robots $4.1B Full Confidence Public Market Cap Observed $880M Partial Confidence
28 Relativity Space Develops reusable heavy-lift rockets $3.5B–$4.5B Low Confidence Proxy-Based Estimate Estimated $1.3B Partial Confidence
29 Form Energy Multi-day iron-air batteries $3.4B–$4.4B Partial Confidence Active Raise Valuation Estimated $1.2B Strong Confidence
30 SiFive RISC-V processor intellectual property $3.7B Full Confidence Announced Private Round Valuation Observed $765M Strong Confidence
31 Xanadu Photonic quantum computing systems $3.4B Full Confidence Public Market Cap Observed $552M Strong Confidence
32 Celestial AI Photonic interconnects for AI infrastructure $3.3B Full Confidence Acquisition Value Observed $581M Strong Confidence
33 Tenstorrent AI chips and RISC-V IP $2.6B–$3.3B Partial Confidence Comparables-Based Estimate Estimated $1.0B Strong Confidence
34 ArsenalBio Engineers cancer cell therapies $2.2B–$3.6B Partial Confidence Implied Valuation from Raise Implied $630M Full Confidence
35 Insilico Medicine AI drug discovery and development $2.9B Full Confidence Public Market Cap Observed $518M Strong Confidence
36 Astranis Builds MicroGEO satellites $2.7B–$2.9B Strong Confidence Announced Private Round Valuation Observed $808M Strong Confidence
37 ElevateBio Cell and gene therapy platform $2.2B–$3.4B Low Confidence Implied Valuation from Raise Estimated $1.2B Full Confidence
38 SambaNova Systems Enterprise AI computing systems $2.0B–$3.5B Low Confidence Implied Valuation from Raise Estimated $1.5B Strong Confidence
39 Enflame Technology Datacenter AI training chips $2.3B–$2.8B Partial Confidence IPO or Listing Range Valuation Estimated $746M Strong Confidence
40 Fourier Intelligence Rehabilitation and humanoid robots $1.2B–$3.9B Low Confidence Comparables-Based Estimate Estimated $234M Partial Confidence
41 Agility Robotics Warehouse humanoid robots $2.4B–$2.6B Strong Confidence IPO or Listing Range Valuation Observed $641M Partial Confidence
42 AbCellera Discovers therapeutic antibodies $2.5B Full Confidence Public Market Cap Observed $671M Strong Confidence
43 Oxford Quantum Circuits Builds superconducting quantum infrastructure $2.0B–$2.9B Partial Confidence Implied Valuation from Raise Implied $499M Full Confidence
44 Stoke Space Fully reusable launch vehicles $2.0B–$2.8B Partial Confidence Comparables-Based Estimate Estimated $480M Full Confidence
45 True Anomaly Autonomous space-security systems $2.2B Strong Confidence Announced Private Round Valuation Observed $390M Partial Confidence
46 Vast Commercial orbital space stations $1.8B–$2.5B Partial Confidence Implied Valuation from Raise Implied $1.0B Partial Confidence
47 Exotec Warehouse automation robot systems $1.8B–$2.4B Partial Confidence Comparables-Based Estimate Estimated $446M Strong Confidence
48 d-Matrix Builds AI inference accelerators $1.9B–$2.2B Strong Confidence Announced Private Round Valuation Estimated $450M Strong Confidence
49 Axiom Space Commercial space stations $1.8B–$2.2B Partial Confidence Announced Private Round Valuation Observed $600M Partial Confidence
50 Generate:Biomedicines AI-designed protein therapeutics $2.0B Full Confidence Public Market Cap Observed $1.1B Strong Confidence
51 Recursion Uses AI for drug discovery $2.0B Full Confidence Public Market Cap Observed $1.2B Strong Confidence
52 Pasqal Builds neutral-atom quantum computers $1.8B–$2.2B Partial Confidence IPO or Listing Range Valuation Estimated $335M Strong Confidence
53 HawkEye 360 Satellite radio-frequency intelligence $1.9B Full Confidence Public Market Cap Observed $560M Partial Confidence
54 Insitro Machine-learning drug discovery platform $1.5B–$2.2B Low Confidence Comparables-Based Estimate Estimated $643M Full Confidence
55 Dexterity Automates warehouse material handling $1.5B–$1.9B Strong Confidence Announced Private Round Valuation Estimated $291M Partial Confidence
56 Lyten Lithium-sulfur batteries and graphene $1.3B–$2.1B Partial Confidence Implied Valuation from Raise Implied $610M Partial Confidence
57 EGenesis Engineers transplantable animal organs $1.3B–$2.0B Partial Confidence Implied Valuation from Raise Implied $454M Strong Confidence
58 Sila Nanotechnologies Silicon battery anode materials $1.3B–$2.0B Low Confidence Proxy-Based Estimate Estimated $1.3B Partial Confidence
59 Locus Robotics Autonomous warehouse fulfillment robots $1.3B–$1.8B Partial Confidence Comparables-Based Estimate Estimated $437M Strong Confidence
60 QuEra Computing Develops neutral-atom quantum systems $1.5B–$2.3B Partial Confidence Implied Valuation from Raise Implied $247M Partial Confidence
61 Infleqtion Neutral-atom quantum systems $1.4B Full Confidence Public Market Cap Observed $249M Strong Confidence
62 Loft Orbital Shared satellite infrastructure services $1.1B–$1.4B Strong Confidence Announced Private Round Valuation Estimated $326M Strong Confidence
63 Sana Biotechnology Engineered cell therapies $1.1B Full Confidence Public Market Cap Observed $1.6B Partial Confidence
64 Black Sesame Technologies Autonomous-driving AI chips $1.1B Full Confidence Public Market Cap Observed $633M Partial Confidence
65 IQM Quantum Computers Superconducting quantum computing systems $1.0B–$1.2B Strong Confidence Announced Private Round Valuation Observed $600M Partial Confidence
66 Isar Aerospace Small-satellite orbital launch vehicles $900M–$1.3B Partial Confidence Implied Valuation from Raise Estimated $418M Strong Confidence
67 Hailo Low-power edge AI processors $900M–$1.3B Partial Confidence Comparables-Based Estimate Estimated $341M Full Confidence
68 Mujin Intelligent industrial robot automation $900M–$1.1B Strong Confidence Announced Private Round Valuation Observed $218M Partial Confidence
69 Boston Metal Emissions-free metals production $850M–$1.1B Partial Confidence Implied Valuation from Raise Estimated $407M Partial Confidence
70 Mammoth Biosciences CRISPR therapeutics and diagnostics $800M–$1.1B Partial Confidence Comparables-Based Estimate Estimated $263M Strong Confidence
71 SEEQC Digital quantum computing chips $800M–$1.0B Partial Confidence Proxy-Based Estimate Estimated $64M Partial Confidence
72 Atom Computing Neutral-atom quantum computers $750M–$1.1B Partial Confidence Implied Valuation from Raise Implied $180M Strong Confidence
73 AMP Robotics Recycling sortation automation $650M–$950M Partial Confidence Implied Valuation from Raise Implied $268M Strong Confidence
74 Alice & Bob Cat-qubit quantum computers $700M–$1.1B Partial Confidence Implied Valuation from Raise Implied $137M Full Confidence
75 Lilac Solutions Direct lithium extraction technology $700M–$950M Partial Confidence Implied Valuation from Raise Estimated $316M Strong Confidence
76 Quantum Machines Quantum computing control systems $650M–$800M Partial Confidence Announced Private Round Valuation Estimated $263M Full Confidence
77 Collaborative Robotics Adaptable collaborative robots $550M–$800M Partial Confidence Implied Valuation from Raise Implied $140M Full Confidence
78 Tessera Therapeutics Gene-writing medicines platform $550M–$800M Low Confidence Proxy-Based Estimate Estimated $580M Strong Confidence
79 Alif Semiconductor Edge AI chips $450M–$800M Low Confidence Comparables-Based Estimate Estimated $186M Partial Confidence
80 Graphcore Intelligence processing AI chips $600M Strong Confidence Acquisition Value Observed $682M Partial Confidence
81 Ginkgo Bioworks Programmable-cell biotechnology platform $592M Full Confidence Public Market Cap Observed $2.4B Strong Confidence
82 Classiq Quantum software platform $480M–$600M Strong Confidence Announced Private Round Valuation Estimated $180M Strong Confidence
83 The Exploration Company Reusable orbital cargo capsules $450M–$650M Partial Confidence Comparables-Based Estimate Estimated $210M Full Confidence
84 GreyOrange Warehouse robotics and orchestration $400M–$700M Partial Confidence Comparables-Based Estimate Estimated $480M Partial Confidence
85 D-Orbit In-space logistics services $425M–$600M Partial Confidence Implied Valuation from Raise Estimated $219M Partial Confidence
86 Solid Power Solid-state electric-vehicle batteries $522M Full Confidence Public Market Cap Observed $750M Partial Confidence
87 Riverlane Quantum error-correction systems $375M–$625M Partial Confidence Implied Valuation from Raise Implied $118M Full Confidence
88 Quandela Photonic quantum computing systems $300M–$500M Low Confidence Comparables-Based Estimate Estimated $71M Strong Confidence
89 Covariant Robotic foundation models $300M–$550M Low Confidence Proxy-Based Estimate Estimated $222M Full Confidence
90 Berkshire Grey Warehouse robotic automation $375M Full Confidence Acquisition Value Observed $676M Partial Confidence
91 ANYbotics Inspection robot dogs $250M–$450M Partial Confidence Comparables-Based Estimate Estimated $152M Strong Confidence
92 Kneron Edge AI processors and software $250M–$400M Low Confidence Comparables-Based Estimate Estimated $170M Partial Confidence
93 Capella Space Radar-imaging satellites $310M Full Confidence Acquisition Value Observed $176M Partial Confidence
94 Astrobotic Lunar robotics and landers $300M Strong Confidence Acquisition Value Observed $3M Low Confidence
95 Sanctuary AI General-purpose humanoid robots $220M–$350M Low Confidence Comparables-Based Estimate Estimated $100M Partial Confidence
96 Metagenomi Gene-editing therapeutic technologies $47M Full Confidence Public Market Cap Observed $444M Full Confidence
97 Universal Quantum Trapped-ion quantum computer hardware $25M–$50M Low Confidence Proxy-Based Estimate Estimated $5M Partial Confidence

Key valuation trends in the deep tech market

Insights

  • SpaceX accounts for roughly 76% of the combined valuation in this deep tech ranking, showing how one scaled space platform can reshape the economics of an otherwise diverse market.
  • Figure AI, Skild AI and Apptronik carry approximately $59 billion in combined valuation after raising about $4.6 billion, reflecting the premium investors place on general-purpose humanoid robotics.
  • IonQ, Rigetti Computing, Infleqtion and Xanadu represent approximately $27 billion in public quantum computing value, compared with about $4.2 billion in identified funding.
  • Colossal Biosciences has a valuation above $10 billion after raising $435 million, producing a valuation-to-funding ratio of roughly 25 times at the midpoint.
  • Planet Labs has a market capitalization of about $9.4 billion, more than ten times its identified funding, which makes Planet Labs a notable capital-efficiency result in space infrastructure.
  • Groq and Skild AI have each raised about $1.8 billion, but Skild AI commands nearly twice Groq's midpoint valuation, suggesting a stronger current premium for robotics foundation models.
  • Celestial AI's $3.3 billion acquisition value equals roughly 5.7 times its identified funding, highlighting the strategic importance of photonic interconnects for AI datacenter expansion.
  • Deep tech public markets show severe outcome dispersion. AbCellera remains valued near $2.5 billion, while Ginkgo Bioworks and Metagenomi trade far below the capital invested in the companies.
  • SiFive's $3.7 billion valuation is almost five times its $765 million funding, showing how RISC-V intellectual property can create infrastructure-like value without owning semiconductor fabrication plants.
  • Warehouse robotics has produced mixed outcomes. Exotec and Locus Robotics remain valued at several times funding, while Berkshire Grey's acquisition value fell below its cumulative capital raised.

A few word about our methodology

As you can see, we built a database that ranks startups and technology companies in the deep tech market based on their current valuation.

Estimating deep tech startup valuations is not always straightforward. Many companies do not publicly disclose their valuation, and available information can vary widely by company, technology and stage.

Deep tech companies can also require long development periods, specialized facilities, regulatory approvals and significant research spending. These factors make simple comparisons difficult.

To build this ranking, we applied a structured valuation methodology and cross-checked information across multiple reliable sources.

Whenever possible, we relied on direct disclosures. These include announced valuations from completed funding rounds, public filings for listed companies and official acquisition prices.

When a deep tech company is publicly listed, we use its current market capitalization as the reference valuation.

If a company was acquired and no independent valuation can reasonably be estimated today, we use the acquisition price as the main reference point.

When a startup recently raised capital but the valuation was not disclosed, we estimate the implied valuation using typical dilution levels for that stage of fundraising.

In some cases, we estimate valuations using operating metrics such as revenue, contracted orders, annual recurring revenue, commercial deployments or customer traction.

We combine these metrics with valuation multiples from comparable companies in the same deep tech segment.

The relevant comparison depends on the company. A quantum computing startup requires a different framework from a biotechnology platform, a semiconductor company or a commercial space business.

When direct financial data is not available, we may use carefully selected comparable startups and other signals such as hiring growth, investor quality, patents, technical milestones, manufacturing progress or product adoption.

All estimates follow a strict evidence hierarchy. Recent funding rounds with announced valuations carry the most weight, followed by strong operating metrics and comparable company analysis.

We also evaluate the age of every data point. Recent information carries more weight, while older information is treated cautiously and adjusted conservatively when necessary.

Whenever information is uncertain or incomplete, we clearly distinguish between confirmed facts and reasonable inferences.

Because valuation data is not always fully public, each company in the ranking is assigned a confidence level based on the reliability, recency and consistency of the available evidence.

Full confidence means the valuation is supported by strong and recent evidence. Strong confidence means the estimate is well supported but includes minor inference. Partial confidence means the estimate relies more heavily on indirect signals. Low confidence means available information is limited or inconsistent.

When confidence is lower, we take a more conservative approach by widening the valuation range. This reflects the uncertainty and increases the probability that the true valuation falls within the estimated range.

In a world where LLMs hallucinate and unreliable information is everywhere, our goal is simple: provide data you can trust.

If you want the full detail on a specific valuation estimate, feel free to contact us and we will gladly explain.

Finally, know that we update the dataset once per month, so come back here if you need fresh information.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.

Back to blog